The Pharma Market Access Pricing and Reimbursement Conference 2013 is dedicated to developments impacting the future of pharmaceutical reimbursement and pricing, including:
- Implementation of market access strategies during early development stages
- Evidence development for reimbursement and market access
- The impact of comparative effectiveness research on reimbursement
- Alternative (shared risk) pricing schemes in theory and practice
- Value-based pricing and its future
- Partnering with payers and providers
- Case studies of various pricing schemes in action
- Health Technology Assessments (HTAs)
- The coming implementation of the PPACA and its impact on public reimbursement schemes
- Integration of payer requirements into product development
- Collection and analysis of reimbursement evidence
- Quantification of economic value
Who should Attend
Attendees interested in pharmaceutical pricing and reimbursement with responsibilities in:
- Chief Medical Officers
- Business Development
- Commercialization
- Chief Pharmacy Officers
- Comparative Effectiveness
- Commercial Operations
- Government, Payer & Stakeholder Relations
- Evidence-Based Medicine
- Health Outcomes
- Health Economics
- HTA
- Health Policy
- Market Access
- Managed Markets
- Medical Affairs
- Marketing
- New Product Planning
- National Accounts
- Pricing & Reimbursement
- Portfolio Management
- Reimbursement
- Product /Brand Management
- Strategic Accounts
- Sales
- Strategic Pricing